(Q35085676)

6 August 2017

1 reference

title

Pharmacokinetic strategies in deciphering atypical drug absorption profiles (English)

1 reference

6 August 2017

1 reference

Honghui Zhou

1

1 reference

6 August 2017

publication date

1 March 2003

1 reference

The Journal of Clinical Pharmacology

6 August 2017

published in

1 reference

6 August 2017

volume

43

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

211-227

1 reference

Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Factors and conditions affecting the glucuronidation of oxazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Role of transport proteins in drug absorption, distribution and excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The P-glycoprotein efflux pump: how does it transport drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The drug efflux-metabolism alliance: biochemical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The multidrug resistance protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The impact of efflux transporters in the brain on the development of drugs for CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Clinical Pharmacokinetics of Digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Improvement in site-specific intestinal absorption of furosemide by Eudragit L100-55.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetic considerations in the adolescent: non-cytochrome P450 metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetics and renal function in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Gender differences in human pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Clinical pharmacokinetics of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

An incremental method for the study of the absorption of drugs whose kinetics are described by a two-compartment model: estimation of the microscopic rate constants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Interpretation of plasma concentration-time curves after oral dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Anomalous parameter estimates in the one-compartment model with first-order absorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Evaluating drug absorption after oral administration. Some problems and some solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Absorption Kinetics of Hydroflumethiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The area function method for assessing the drug absorption rate in linear systems with zero-order input.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Simultaneous investigation of absorption and disposition kinetics using stable isotopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Population PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetics of an oral sustained-release diltiazem preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetic analysis of concentration data of drugs with irregular absorption profiles using multi-fraction absorption models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetics and bioavailability of cimetidine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Absorption and metabolism of lanatoside C. II. Fate after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Penicillamine kinetics in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetic Analysis by Linear System Approach I: Cimetidine Bioavailability and Second Peak Phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Value of plasma-digoxin estimation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Dose-dependent absorption and elimination of cefadroxil in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Mixed effect modeling of sumatriptan pharmacokinetics during drug development: II. From healthy subjects to phase 2 dose ranging in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Use of nonlinear mixed effect modeling for the meta-analysis of preclinical pharmacokinetic data: application to S 20342 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

A double Weibull input function describes the complex absorption of sustained-release oral sodium valproate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Effect of meal timing not critical for the pharmacokinetics of tegaserod (HTF 919).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Factors affecting the absorption of riboflavin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Time-dependent oral absorption models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

A novel extravascular input function for the assessment of drug absorption in bioavailability studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Effects of cardiac output on disposition kinetics of sorbitol: recirculatory modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Commentary: using the convection-dispersion model and transit time density functions in the analysis of organ distribution kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002250613

21 January 2018

Identifiers

DOI

10.1177/0091270002250613

1 reference

6 August 2017

1 reference